Biology of Blood and Marrow Transplantation
Volume 12, Issue 3 , Pages 243-251 , March 2006

Adenoviral Infections in Hematopoietic Stem Cell Transplantation

Received 20 September 2005 ,Accepted 24 October 2005.

References 

  1. Gaggar A , Shayakhmetov DM , Lieber A . CD46 is a cellular receptor for group B adenoviruses . Nat Med . 2003;9:1408–1412
  2. Gaggar A , Shayakhmetov DM , Liszewski MK , Atkinson JP , Lieber A . Localization of regions in CD46 that interact with adenovirus . J Virol . 2005;79:7503–7513
  3. Arnberg N , Edlund K , Kidd AH , Wadell G . Adenovirus type 37 uses sialic acid as a cellular receptor . J Virol . 2000;74:42–48
  4. Shayakhmetov DM , Li ZY , Ternovoi V , Gaggar A , Gharwan H , Lieber A . The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses . J Virol . 2003;77:3712–3723
  5. Greber UF , Suomalainen M , Stidwill RP , Boucke K , Ebersold MW , Helenius A . The role of the nuclear pore complex in adenovirus DNA entry . EMBO J . 1997;16:5998–6007
  6. Greber UF , Webster P , Weber J , Helenius A . The role of the adenovirus protease on virus entry into cells . EMBO J . 1996;15:1766–1777
  7. Leopold PL , Kreitzer G , Miyazawa N , et al.   Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis . Hum Gene Ther . 2000;11:151–165
  8. Suomalainen M , Nakano MY , Keller S , Boucke K , Stidwill RP , Greber UF . Microtubule-dependent plus- and minus end-directed motilities are competing processes for nuclear targeting of adenovirus . J Cell Biol . 1999;144:657–672
  9. Miyazawa N , Crystal RG , Leopold PL . Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein . J Virol . 2001;75:1387–1400
  10. Miyazawa N , Leopold PL , Hackett NR , et al.   Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors . J Virol . 1999;73:6056–6065
  11. Rux JJ , Burnett RM . Adenovirus structure . Hum Gene Ther . 2004;15:1167–1176
  12. Muruve DA . The innate immune response to adenovirus vectors . Hum Gene Ther . 2004;15:1157–1166
  13. Wold WS , Doronin K , Toth K , Kuppuswamy M , Lichtenstein DL , Tollefson AE . Immune responses to adenoviruses (viral evasion mechanisms and their implications for the clinic) . Curr Opin Immunol . 1999;11:380–386
  14. Flomenberg P , Piaskowski V , Truitt RL , Casper JT . Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon . J Virol . 1996;70:6314–6322
  15. Wold WS , Gooding LR . Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor . Mol Biol Med . 1989;6:433–452
  16. Wold WS , Gooding LR . Region E3 of adenovirus (a cassette of genes involved in host immunosurveillance and virus–cell interactions) . Virology . 1991;184:1–8
  17. Guidotti LG , Chisari FV . Noncytolytic control of viral infections by the innate and adaptive immune response . Annu Rev Immunol . 2001;19:65–91
  18. Pasare C , Medzhitov R . Toll-like receptors (linking innate and adaptive immunity) . Adv Exp Med Biol . 2005;560:11–18
  19. Heemskerk B , Veltrop-Duits LA , van Vreeswijk T , et al.   Extensive cross-reactivity of CD4+ adenovirus-specific T cells (implications for immunotherapy and gene therapy) . J Virol . 2003;77:6562–6566
  20. Leen AM , Sili U , Savoldo B , et al.   Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications . Blood . 2004;103:1011–1019
  21. Olive M , Eisenlohr L , Flomenberg N , Hsu S , Flomenberg P . The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope . Hum Gene Ther . 2002;13:1167–1178
  22. Olive M , Eisenlohr LC , Flomenberg P . Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults . Viral Immunol . 2001;14:403–413
  23. Kojaoghlanian T , Flomenberg P , Horwitz MS . The impact of adenovirus infection on the immunocompromised host . Rev Med Virol . 2003;13:155–171
  24. Allard A , Girones R , Juto P , Wadell G . Polymerase chain reaction for detection of adenoviruses in stool samples . J Clin Microbiol . 1990;28:2659–2667
  25. Echavarria M , Forman M , Ticehurst J , Dumler JS , Charache P . PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals . J Clin Microbiol . 1998;36:3323–3326
  26. Pring-Akerblom P , Adrian T . Type- and group-specific polymerase chain reaction for adenovirus detection . Res Virol . 1994;145:25–35
  27. Pring-Akerblom P , Adrian T , Kostler T . PCR-based detection and typing of human adenoviruses in clinical samples . Res Virol . 1997;148:225–231
  28. Mercier B , Burlot L , Ferec C . Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay . J Virol Methods . 1999;77:1–9
  29. Morris T , Robertson B , Gallagher M . Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system . J Clin Microbiol . 1996;34:2933–2936
  30. Ryncarz AJ , Goddard J , Wald A , Huang ML , Roizman B , Corey L . Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples . J Clin Microbiol . 1999;37:1941–1947
  31. Wagner HJ , Cheng YC , Huls MH , et al.   Prompt versus preemptive intervention for EBV lymphoproliferative disease . Blood . 2004;103:3979–3981
  32. Heim A , Ebnet C , Harste G , Pring-Akerblom P . Rapid and quantitative detection of human adenovirus DNA by real-time PCR . J Med Virol . 2003;70:228–239
  33. Lion T , Baumgartinger R , Watzinger F , et al.   Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease . Blood . 2003;102:1114–1120
  34. Morfin F , Dupuis-Girod S , Mundweiler S , et al.   In vitro susceptibility of adenovirus to antiviral drugs is species-dependent . Antivir Ther . 2005;10:225–229
  35. Leen AM , Rooney CM . Adenovirus as an emerging pathogen in immunocompromised patients . Br J Haematol . 2005;128:135–144
  36. Baldwin A , Kingman H , Darville M , et al.   Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation . Bone Marrow Transplant . 2000;26:1333–1338
  37. Chakrabarti S , Mautner V , Osman H , et al.   Adenovirus infections following allogeneic stem cell transplantation (incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery) . Blood . 2002;100:1619–1627
  38. Hale GA , Heslop HE , Krance RA , et al.   Adenovirus infection after pediatric bone marrow transplantation . Bone Marrow Transplant . 1999;23:277–282
  39. Howard DS , Phillips GL , Reece DE , et al.   Adenovirus infections in hematopoietic stem cell transplant recipients . Clin Infect Dis . 1999;29:1494–1501
  40. Kampmann B , Cubitt D , Walls T , et al.   Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation . Br J Haematol . 2005;130:595–603
  41. Runde V , Ross S , Trenschel R , et al.   Adenoviral infection after allogeneic stem cell transplantation (SCT) (report on 130 patients from a single SCT unit involved in a prospective multicenter surveillance study) . Bone Marrow Transplant . 2001;28:51–57
  42. Flomenberg P , Babbitt J , Drobyski WR , et al.   Increasing incidence of adenovirus disease in bone marrow transplant recipients . J Infect Dis . 1994;169:775–781
  43. Avivi I , Chakrabarti S , Milligan DW , et al.   Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab . Biol Blood Marrow Transplant . 2004;10:186–194
  44. Leen AM , Sili U , Vanin EF , et al.   Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells . Blood . 2004;104:2432–2440
  45. Smith CA , Woodruff LS , Rooney C , Kitchingman GR . Extensive cross-reactivity of adenovirus-specific cytotoxic T cells . Hum Gene Ther . 1998;9:1419–1427
  46. Feuchtinger T , Lucke J , Hamprecht K , et al.   Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation . Br J Haematol . 2005;128:503–509
  47. van Tol MJ , Kroes AC , Schinkel J , et al.   Adenovirus infection in paediatric stem cell transplant recipients (increased risk in young children with a delayed immune recovery) . Bone Marrow Transplant . 2005;36:39–50
  48. Walls T , Hawrami K , Ushiro-Lumb I , Shingadia D , Saha V , Shankar AG . Adenovirus infection after pediatric bone marrow transplantation (is treatment always necessary?) . Clin Infect Dis . 2005;40:1244–1249
  49. Bordigoni P , Carret AS , Venard V , Witz F , Le Faou A . Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation . Clin Infect Dis . 2001;32:1290–1297
  50. Gavin PJ , Katz BZ . Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children . Pediatrics . 2002;110:e9
  51. Hoffman JA , Shah AJ , Ross LA , Kapoor N . Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation . Biol Blood Marrow Transplant . 2001;7:388–394
  52. La Rosa AM , Champlin RE , Mirza N , et al.   Adenovirus infections in adult recipients of blood and marrow transplants . Clin Infect Dis . 2001;32:871–876
  53. Legrand F , Berrebi D , Houhou N , et al.   Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children . Bone Marrow Transplant . 2001;27:621–626
  54. Ljungman P , Ribaud P , Eyrich M , et al.   Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation (a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation) . Bone Marrow Transplant . 2003;31:481–486
  55. Lankester AC , Heemskerk B , Claas EC , et al.   Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection . Clin Infect Dis . 2004;38:1521–1525
  56. Leruez-Ville M , Minard V , Lacaille F , et al.   Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection . Clin Infect Dis . 2004;38:45–52
  57. Feuchtinger T , Lang P , Hamprecht K , et al.   Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy . Exp Hematol . 2004;32:282–289
  58. Heemskerk B , Lankester AC , van Vreeswijk T , et al.   Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients . J Infect Dis . 2005;191:520–530
  59. Hromas R , Cornetta K , Srour E , Blanke C , Broun ER . Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell–depleted bone marrow transplantation . Blood . 1994;84:1689–1690
  60. Flomenberg P , Piaskowski V , Truitt RL , Casper JT . Characterization of human proliferative T cell responses to adenovirus . J Infect Dis . 1995;171:1090–1096
  61. Smith CA , Woodruff LS , Kitchingman GR , Rooney CM . Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro . J Virol . 1996;70:6733–6740
  62. Regn S , Raffegerst S , Chen X , Schendel D , Kolb HJ , Roskrow M . Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant . Bone Marrow Transplant . 2001;27:53–64
  63. Hamel Y , Blake N , Gabrielsson S , et al.   Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein (a novel approach for immunotherapy) . Hum Gene Ther . 2002;13:855–866
  64. Molinier-Frenkel V , Lengagne R , Gaden F , et al.   Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response . J Virol . 2002;76:127–135
  65. Tang J , Olive M , Champagne K , et al.   Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele . Gene Ther . 2004;11:1408–1415
  66. Crawford-Miksza L , Schnurr DP . Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues . J Virol . 1996;70:1836–1844
  67. Piedra PA , Poveda GA , Ramsey B , McCoy K , Hiatt PW . Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis (implication for gene therapy with adenovirus vectors) . Pediatrics . 1998;101:1013–1019
  68. Rux JJ , Kuser P , Burnett RM . Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods . J Virol . 2003;77:9553–9566
  69. Rux JJ , Burnett RM . Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon . Mol Ther . 2000;1:18–30
  70. Horwitz MS . Adenoviruses . In: 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 2301–2326
  71. Shenk TE . Adenoviridae (The Viruses and Their Replication) . In: 4th ed.. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 2265–2300
  72. Shayakhmetov DM , Lieber A . Dependence of adenovirus infectivity on length of the fiber shaft domain . J Virol . 2000;74:10274–10286
  73. Yotnda P , Onishi H , Heslop HE , et al.   Efficient infection of primitive hematopoietic stem cells by modified adenovirus . Gene Ther . 2001;8:930–937
  74. Busch DH , Pamer EG . T cell affinity maturation by selective expansion during infection . J Exp Med . 1999;189:701–709
  75. Haanen J , Wolkers MC , Kruisbeek AM , Schumacher TN . Selective expansion of cross-reactive CD8+ memory T cells by viral variants . J Exp Med . 1999;190:1319–1328
  76. Bollard CM , Kuehnle I , Leen A , Rooney CM , Heslop HE . Adoptive immunotherapy for posttransplantation viral infections . Biol Blood Marrow Transplant . 2004;10:143–155
  77. Heslop HE , Ng CYC , Li C , et al.   Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes . Nat Med . 1996;2:551–555
  78. Riddell SR , Walter BA , Gilbert MJ , Greenberg PD . Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cells clones . Bone Marrow Transplant . 1994;14:S78–S84
  79. Rooney CM , Smith CA , Ng C , et al.   Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus–related lymphoproliferation . Lancet . 1995;345:9–13
  80. Rooney CM , Smith CA , Ng CY , et al.   Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus–induced lymphoma in allogeneic transplant recipients . Blood . 1998;92:1549–1555
  81. Walter EA , Greenberg PD , Gilbert MJ , et al.   Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor . N Engl J Med . 1995;333:1038–1044
  82. Einsele H , Roosnek E , Rufer N , et al.   Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy . Blood . 2002;99:3916–3922
  83. Kozarsky KF , Wilson JM . Gene therapy (adenovirus vectors) . Curr Opin Genet Dev . 1993;3:499–503

PII: S1083-8791(05)00724-X

doi: 10.1016/j.bbmt.2005.10.024

Biology of Blood and Marrow Transplantation
Volume 12, Issue 3 , Pages 243-251 , March 2006

Article Tools

* Image Usage & Resolution